Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ONYX Pharmaceuticals
ONYX Pharmaceuticals
Biotech 2012 Kickoff Party: Investor Preview
TheStreet.com
Wed, 01/4/12 - 10:22 am
Celgene
Vivus
Dendreon
Gilead
Incyte
YM BioSciences
ONYX Pharmaceuticals
Seattle Genetics
Vertex
Amarin
Biomarin
Biogen Idec
Regeneron
Merck KGaA
Human Genome Sciences
Clovis Oncology
Roche
Ariad
Immunogen
Medivation
Geron
InterMune
Indenix
Amag Pharmaceuticals
Mesoblast
Arena
MannKind
Keryx
Spectrum Pharmaceuticals
Onyx put selling hinges on time decay
Yahoo/optionMONSTER
Thu, 12/29/11 - 12:01 pm
ONYX Pharmaceuticals
regorafenib
Biotech Stock Mailbag: Most Important Events for 2012
TheStreet.com
Fri, 12/23/11 - 08:56 am
Oncothyreon
Keryx
Vical
Aeterna Zentaris
Eli Lilly
JNJ
Elan
Celgene
Pfizer
Gilead
Pharmasset
Threshold Pharmaceuticals
Celldex
Amgen
BioVex
Aveo Pharmaceutical
Amylin
Alkermes
Vertex
Cell Therapeutics
Amarin
ONYX Pharmaceuticals
Vivus
Bristol-Myers Says Liver Cancer Drug Didn’t Meet Goals in Trial
Bloomberg
Fri, 12/23/11 - 08:44 am
liver cancer
Bristol-Myers Squibb
brivanib
Nexavar
ONYX Pharmaceuticals
Bayer
10 Biotech Stock Predictions for 2012
TheStreet.com
Tue, 12/20/11 - 11:13 am
Amgen
FDA
Oncothyreon
Merck KGaA
Vical
GSK
Seattle Genetics
M&A
Celgene
Biomarin
Amag Pharmaceuticals
Momenta
ONYX Pharmaceuticals
Cell Therapeutics
Roche
Aeterna Zentaris
Arena Pharmaceuticals
Vertex
Spectrum Pharmaceuticals
FDA Irony: Less Data, Longer Review
Motley Fool
Mon, 12/12/11 - 10:47 pm
FDA
ONYX Pharmaceuticals
Carfilzomib
9 Biotech Companies With FDA Approval Decision Dates In Q1 2012
Seeking Alpha
Mon, 12/12/11 - 11:14 am
FDA
Fentanyl SL
INSYS Therapeutics
Dapagliflozin
Bristol-Myers Squibb
Prochieve
Columbia Laboratories
Discovery Labs
Surfaxin
NeurogesX
Qutenza
Curis
Roche
vismodegib
Chelsea Therapeutics
Northera
ONYX Pharmaceuticals
Carfilzomib
Onyx shares fall on likely delay in myeloma drug approval
Reuters
Mon, 12/12/11 - 11:04 am
ONYX Pharmaceuticals
myeloma
Carfilzomib
FDA
Five Biotech Stocks to Watch Going into Big Doctors' Meeting
Minyanville
Fri, 12/9/11 - 11:13 am
Seattle Genetics
ONYX Pharmaceuticals
Incyte
Celgene
Ariad Pharmaceuticals
5 High Risk/Reward Biotechs For 2012
Seeking Alpha
Mon, 12/5/11 - 06:13 pm
ONYX Pharmaceuticals
Vertex Pharmaceuticals
Amarin
Chelsea Therapeutics
Cell Therapeutics
December Catalysts for Drug and Biotech Stocks
Minyanville
Sat, 12/3/11 - 11:11 am
Pfizer
Aveo Pharmaceutical
Affymax
Amgen
Antares Pharma
Celgene
ONYX Pharmaceuticals
Seattle Genetics
Micromet
YM BioSciences
Regeneron
BioSante
Pfizer, GSK named in Onyx buyout gossip
Fierce Biotech
Thu, 12/1/11 - 11:48 am
GSK
Pfizer
M&A
ONYX Pharmaceuticals
New Drug Approvals Make Or Break Biotechnology Stocks
Seeking Alpha
Wed, 11/30/11 - 10:46 am
Antares
Achillion
Pharmasset
Indenix
Inhibitex
ONYX Pharmaceuticals
Keryx
Every Biotech Is for Sale
Motley Fool
Wed, 11/30/11 - 10:45 am
ONYX Pharmaceuticals
Achillion
BioSante
Indenix
Inhibitex
GSK
Bristol-Myers Squibb
Amarin
Exelixis
Onyx' Cancer Drug on Right Track
Yahoo/Zacks.com
Wed, 11/30/11 - 10:37 am
ONYX Pharmaceuticals
Carfilzomib
Multiple Myeloma
22 Hot Drugs Facing FDA Approval in 2012
TheStreet.com
Tue, 11/29/11 - 09:09 am
Amarin
AMR101
Ironwood
linaclotide
Merck
Ariad
ridaforolimus
Vivus
Qnexa
Avanafil
Amgen
Xgeva
Cell Therapeutics
pixantrone
Kalydeco
Vertex
ONYX Pharmaceuticals
Carfilzomib
Pfizer
Bristol-Myers Squibb
Eliquis
Chelsea Therapeutics
Northera
Levadex
MAP Pharmaceuticals
Roche
Curis
vismodegib
Biogen Idec
Elan
Tysabri
Amylin
Bydureon
Dapagliflozin
Uplypso
Protalix BioTherapeutics
Teva Pharmaceuticals
BioSante
Bio-T-Gel
Corlux
Corcept Therapeutics
Discovery Labs
Surfaxin
5 Biotechs Posting Big Gains
Motley Fool
Tue, 11/29/11 - 08:31 am
ONYX Pharmaceuticals
Momenta
Micromet
Avanir
Arena Pharmaceuticals
Onyx Pharmaceuticals Said to Weigh Sale as It Explores Strategic Options
Bloomberg
Tue, 11/29/11 - 08:24 am
ONYX Pharmaceuticals
Nexavar
M&A
Carfilzomib
Onyx Pharmaceuticals said to consider sale: report
Marketwatch
Mon, 11/28/11 - 04:46 pm
ONYX Pharmaceuticals
M&A
5 One-Drug Wonders Going for No. 2
Motley Fool
Tue, 11/1/11 - 11:09 am
Dendreon
Provenge
DN24-02
Elan
Tysabri
bapineuzumab
ONYX Pharmaceuticals
Bayer
regorafenib
Carfilzomib
Nexavar
Vertex
Merck
Incivek
Kalydeco
Momenta
Lovenox
Copaxone
Teva Pharmaceuticals
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »